A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...

DERM (Deep Ensemble for Recognition of Malignancy), which was approved in the UK as a Class IIA medical device in 2022, analyses images to assess and triage skin lesions, and may be able to refer ...

PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system ...

DERM (Deep Ensemble for Recognition of Malignancy), developed by Skin Analytics, analyses images to assess and triage skin lesions, potentially redirecting benign cases to non-urgent pathways.

Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

The use of teledermatology and dermoscopy is an effective strategy to screen patients for skin cancer in underserved communities who have suspicious lesions, a new study suggests. 1. The report is ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

With skin cancer on the rise across the UK, Boots is expanding dermatology training for its in-store pharmacists. Matt Nixson ...

A new study published in the Journal of Drugs in Dermatology showed that while maintaining the integrity of the skin barrier, a new salicylic acid (SA)-polymeric cleansing technology (PCT) ...

Medicare covers the removal of benign skin lesions including sebaceous cysts if medically necessary. ... Medicare Part B may cover dermatology care if it’s medically necessary.